Albumin binding ligands and albumin conjugate uptake by cancer cells

Diabetology and Metabolic Syndrome

Volumn 3, Issue 1, 2011, Pages

  Frei, Eva ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

aminofluorescein albumin; clathrin heavy chain; fatty acids; Insulin detemir; lysosomes; methotrexate albumin

Indexed keywords

ALBUMIN; ALBUMIN CONJUGATE; DRUG CARRIER; FATTY ACID DERIVATIVE; HUMAN INSULIN; HUMAN SERUM ALBUMIN; INSULIN; INSULIN DETEMIR; LONG CHAIN FATTY ACID; METHOTREXATE;

CANCER CELL; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG RELEASE; DRUG TRANSPORT; DRUG UPTAKE; ENDOCYTOSIS; HUMAN; INFLAMMATION; KIDNEY CARCINOMA; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

EID: 79958769656     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-3-11     Document Type: Review

References (18)

1. Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence. I Hartman, Clin Med Res 2008 6 54 67 10.3121/cmr.2008.793 18801953
2. T Peters, All about Albumin: Biochemistry, Genetics, and Medical Applications San Diego: Academic Press 1996
3. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats. G Stehle H Sinn A Wunder HH Schrenk S Schutt W Maier-Borst DL Heene, Anticancer Drugs 1997 8 677 685 9311444 (Pubitemid 27404725)
4. Native albumin for targeted drug delivery. E Neumann E Frei D Funk MD Becker HH Schrenk U Muller-Ladner C Fiehn, Expert Opin Drug Deliv 2010 7 915 925 10.1517/17425247.2010.498474 20586704
5. Plasma protein (albumin) catabolism by the tumor itself - implications for tumor metabolism and the genesis of cachexia. G Stehle H Sinn A Wunder HH Schrenk JC Stewart G Hartung W Maier-Borst DL Heene, Crit Rev Oncol Hematol 1997 26 77 100 10.1016/S1040-8428(97)00015-2 9298326 (Pubitemid 27362424)
6. Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins. JE Schnitzer P Oh, J Biol Chem 1994 269 6072 6082 8119952
7. Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status. NP Desai V Trieu LY Hwang R Wu P Soon-Shiong WJ Gradishar, Anticancer Drugs 2008 19 899 909 10.1097/CAD.0b013e32830f9046 18766004
8. Isolation and identification of heterogeneous nuclear ribonucleoproteins (hnRNP) from purified plasma membranes of human tumour cell lines as albumin-binding proteins. T Fritzsche M Schnolzer S Fiedler M Weigand M Wiessler E Frei, Biochem Pharmacol 2004 67 655 665 10.1016/j.bcp.2003.09.027 14757165 (Pubitemid 38125250)
9. Endocytic response of type I alveolar epithelial cells to hypertonic stress. S Wang RD Singh L Godin RE Pagano RD Hubmayr, Am J Physiol Lung Cell Mol Physiol 2011 300 560 L568 10.1152/ajplung.00309.2010 21257731
10. Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis. A Wunder U Muller-Ladner EH Stelzer J Funk E Neumann G Stehle T Pap H Sinn S Gay C Fiehn, J Immunol 2003 170 4793 4801 12707361 (Pubitemid 36519989)
11. Intraoperative fluorescence staining of malignant brain tumors using 5-aminofluorescein-labeled albumin. P Kremer M Fardanesh R Ding M Pritsch S Zoubaa E Frei, Neurosurgery 2009 64 53 60 19240573
12. Pharmacokinetics of 5-Aminofluorescein-Albumin, a Novel Fluorescence Marker of Brain Tumors During Surgery. R Ding E Frei M Fardanesh HH Schrenk P Kremer WE Haefeli, J Clin Pharmacol 2011 51 672 678 10.1177/0091270010372626 20978277
13. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society. G Hartung G Stehle H Sinn A Wunder HH Schrenk S Heeger M Kranzle L Edler E Frei HH Fiebig DL Heene W Maier-Borst W Queisser, Clin Cancer Res 1999 5 753 759 10213209 (Pubitemid 29180825)
14. A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy. AN Vis A van der Gaast BW van Rhijn TK Catsburg C Schmidt GH Mickisch, Cancer Chemother Pharmacol 2002 49 342 345 10.1007/s00280-001-0417-z 11914915 (Pubitemid 34253274)
15. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. K Wosikowski E Biedermann B Rattel N Breiter P Jank R Loser G Jansen GJ Peters, Clin Cancer Res 2003 9 1917 1926 12738750 (Pubitemid 36554620)
16. Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor. AR Sorensen CE Stidsen U Ribel E Nishimura J Sturis I Jonassen SD Bouman P Kurtzhals CL Brand, Diabetes Obes Metab 2010 12 665 673 10.1111/j.1463-1326.2010.01206.x 20590743
17. Effect of fatty acids and selected drugs on the albumin binding of a long-acting, acylated insulin analogue. P Kurtzhals S Havelund I Jonassen J Markussen, J Pharm Sci 1997 86 1365 1368 10.1021/js9701768 9423147 (Pubitemid 28018315)
18. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. N Abumrad C Coburn A Ibrahimi, Biochim Biophys Acta 1999 1441 4 13 10526223 (Pubitemid 29469432)